Multiple Ascending Dose of BMS-911543

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 7, 2011

Primary Completion Date

November 19, 2015

Study Completion Date

November 19, 2015

Conditions

Cancer

Interventions

DRUG

BMS-911543

Trial Locations (5)

Local Institution, East Melbourne

Local Institution, Melbourne

The Mount Sinai School Of Medicine, New York

Mayo Clinic, Rochester

The University Of Texas Md Anderson Cancer Center, Houston